Graf Martin R, Sauer Jeremy T, Merchant Randall E
Department of Neurosurgery, Virginia Commonwealth University Medical Center, Richmond, Virginia, 23298-0631, USA.
J Neurooncol. 2005 May;73(1):29-36. doi: 10.1007/s11060-007-9442-z.
We have recently reported that activation of tumor-specific T cells by subcutaneous vaccination with irradiated T9 glioma cells of syngeneic rats with a pre-existing, intracranial (i.c.) T9 glioma (T9+vaccination) promotes the mobilization of myeloid suppressor cells (MSC) which inhibit T cell function resulting in unregulated tumor progression. The current study investigated if this immunological paradigm could be recapitulated in T cell deficient rats, in other rat glioma models or using a dendritic cell (DC) vaccine. When nude rats were used in the T9+vaccination model, the level of MSC tumor infiltration remained low in vaccinated and control groups and there was no significant difference in tumor size between the groups. Increased tumor infiltration by MSC after vaccination with respective irradiated tumor cells was observed in the 9L, F98 and D74 gliomas. RT-2 tumors were markedly infiltrated with MSC regardless of vaccination. Enhanced tumor progression in response to immunization and T cell activation was observed in rats bearing F98 and D74 gliomas, although less pronounced than in the T9 model, and there was a trend for increased tumor size in the 9L glioma model. Increased MSC infiltrate and augmented T9 glioma growth were observed when DC pulsed with T9 cell lysate was used as a vaccine. These results suggest that MSC infiltration and unregulated tumor growth in response to vaccination is T cell-dependent; is not unique to the T9 glioma; and can be recapitulated with an alternate immunization approach.
我们最近报道,对预先存在颅内T9胶质瘤的同基因大鼠皮下接种经照射的T9胶质瘤细胞(T9 + 疫苗接种)来激活肿瘤特异性T细胞,会促进髓系抑制细胞(MSC)的动员,而这些细胞会抑制T细胞功能,导致肿瘤进展失控。当前研究调查了这种免疫模式是否能在T细胞缺陷大鼠、其他大鼠胶质瘤模型中重现,或者使用树突状细胞(DC)疫苗来重现。在T9 + 疫苗接种模型中使用裸鼠时,接种组和对照组中MSC肿瘤浸润水平仍然较低,两组之间肿瘤大小没有显著差异。在9L、F98和D74胶质瘤模型中,接种相应经照射的肿瘤细胞后观察到MSC肿瘤浸润增加。无论是否接种疫苗,RT - 2肿瘤均有明显的MSC浸润。在携带F98和D74胶质瘤的大鼠中,观察到免疫和T细胞激活后肿瘤进展增强,尽管不如T9模型明显,并且在9L胶质瘤模型中存在肿瘤大小增加的趋势。当使用用T9细胞裂解物脉冲处理的DC作为疫苗时,观察到MSC浸润增加和T9胶质瘤生长加剧。这些结果表明,接种疫苗后MSC浸润和肿瘤生长失控是T细胞依赖性的;并非T9胶质瘤所特有;并且可以通过另一种免疫方法重现。